{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:08:19Z","timestamp":1791547699801,"version":"4.3.4"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1023\/a:1011456309039","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T10:16:33Z","timestamp":1040638593000},"page":"301-315","source":"Crossref","is-referenced-by-count":17,"title":["Endothelin A Receptor Antagonists in Congestive Heart Failure: Blocking the Beast while Leaving the Beauty Untouched?"],"prefix":"10.1007","volume":"6","author":[{"given":"Lukas E.","family":"Spieker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank T.","family":"Ruschitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Lu\u00a8scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"352399_CR1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411\u2013415.","journal-title":"Nature"},{"key":"352399_CR2","doi-asserted-by":"crossref","first-page":"C550","DOI":"10.1152\/ajpcell.1985.248.5.C550","volume":"248","author":"KA Hickey","year":"1985","unstructured":"Hickey KA, Rubanyi G, Paul RJ, Highsmith RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985;248:C550\u2013C556.","journal-title":"Am J Physiol"},{"key":"352399_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/oxfordjournals.eurheartj.a059542","volume":"10","author":"H Eriksson","year":"1989","unstructured":"Eriksson H, Svardsudd K, Larsson B. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989;10:647\u2013656.","journal-title":"Eur Heart J"},{"key":"352399_CR4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0002-8703(93)90738-U","volume":"26","author":"RF. Gillum","year":"1993","unstructured":"Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993;26:1042\u20131047.","journal-title":"Am Heart J"},{"key":"352399_CR5","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","volume":"22","author":"KK Ho","year":"1993","unstructured":"Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A\u201313A.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441\u20131446.","journal-title":"N Engl J Med"},{"key":"352399_CR7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.CIR.85.4.1374","volume":"85","author":"JJ McMurray","year":"1992","unstructured":"McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374\u20131379.","journal-title":"Circulation"},{"key":"352399_CR8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-6196(12)60795-2","volume":"67","author":"RJ Rodeheffer","year":"1992","unstructured":"Rodeheffer RJ, Lerman A, Heublein DM, Burnett JJ. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992;67:719\u2013724.","journal-title":"Mayo Clin Proc"},{"key":"352399_CR9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.89.4.1580","volume":"89","author":"CM Wei","year":"1994","unstructured":"Wei CM, Lerman A, Rodeheffer RJ. Endothelin in human congestive heart failure. Circulation 1994;89:1580\u20131586.","journal-title":"Circulation"},{"key":"352399_CR10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0002-9149(98)00092-7","volume":"81","author":"AE Tuinenburg","year":"1998","unstructured":"Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van Den Berg MP, De Kam PJ, Crijns HJ. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 1998;81:1207\u20131210.","journal-title":"Am J Cardiol"},{"key":"352399_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0735-1097(95)00520-X","volume":"27","author":"R Pacher","year":"1996","unstructured":"Pacher R, Stanek B, H\u00fclsmann M. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633\u2013641.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0006-291X(90)91198-2","volume":"171","author":"R Ikegawa","year":"1990","unstructured":"Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem Biophys Res Commun 1990;171:669\u2013675.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR13","doi-asserted-by":"crossref","first-page":"21394","DOI":"10.1016\/S0021-9258(19)36936-4","volume":"268","author":"M Takahashi","year":"1993","unstructured":"Takahashi M, Matsushita Y, lijima Y, Tanzawa K. Purification and characterization of endothelinconverting enzyme from rat lung. J Biol Chem 1993;268:21394\u201321398.","journal-title":"J Biol Chem"},{"key":"352399_CR14","doi-asserted-by":"crossref","first-page":"26759","DOI":"10.1016\/S0021-9258(19)74378-6","volume":"268","author":"K. Ohnaka","year":"1993","unstructured":"Ohnaka K, Takayanagi R, Nishikawa M, Haji M, Nawata H. Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. J Biol Chem 1993;268:26759\u201326766.","journal-title":"J Biol Chem"},{"key":"352399_CR15","doi-asserted-by":"crossref","first-page":"18275","DOI":"10.1016\/S0021-9258(17)32298-6","volume":"269","author":"K. Shimada","year":"1994","unstructured":"Shimada K, Takahashi M, Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 1994;269:18275\u201318278.","journal-title":"J Biol Chem"},{"key":"352399_CR16","doi-asserted-by":"crossref","first-page":"14954","DOI":"10.1016\/S0021-9258(18)63795-0","volume":"264","author":"A Inoue","year":"1989","unstructured":"Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 1989;264:14954\u201314959.","journal-title":"J Biol Chem"},{"key":"352399_CR17","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1073\/pnas.86.8.2863","volume":"86","author":"A Inoue","year":"1989","unstructured":"Inoue A, Yanagisawa M, Kimura S. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863\u20132867.","journal-title":"Proc Natl Acad Sci USA"},{"key":"352399_CR18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0006-291X(89)90817-6","volume":"162","author":"G Fleminger","year":"1989","unstructured":"Fleminger G, Bousso-Mittler D, Bdolah A, Kloog Y, Sokolovsky M. Immunological and structural characterization of sarafotoxin\/endothelin family of peptides. Biochem Biophys Res Commun 1989;162:1317\u20131323.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(89)80958-5","volume":"253","author":"Y Kloog","year":"1989","unstructured":"Kloog Y, Bousso-Mittler D, Bdolah A, Sokolovsky M. Three apparent receptor subtypes for the endothelin\/ sarafotoxin family. FEBS Lett 1989;253:199\u2013202.","journal-title":"FEBS Lett"},{"key":"352399_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.2845579","volume":"242","author":"Y Kloog","year":"1988","unstructured":"Kloog Y, Ambar I, Sokolovsky M, Kochva E, Wollberg Z, Bdolah A. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 1988;242:268\u2013270.","journal-title":"Science"},{"key":"352399_CR21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1172\/JCI114477","volume":"85","author":"C Boulanger","year":"1990","unstructured":"Boulanger C, L\u00fcscher TF. Release of endothelin from the porcine aorta. Inhibition of endothelium-derived nitric oxide. J Clin Invest 1990;85:587\u2013590.","journal-title":"J Clin Invest"},{"key":"352399_CR22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.RES.70.6.1191","volume":"70","author":"CM Boulanger","year":"1992","unstructured":"Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, L\u00fcscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70:1191\u20131197.","journal-title":"Circ Res"},{"key":"352399_CR23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-291X(89)92679-X","volume":"161","author":"M Yoshizumi","year":"1989","unstructured":"Yoshizumi M, Kurihara H, Sugiyama T. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;161:859\u2013864.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115367","volume":"88","author":"S Kourembanas","year":"1991","unstructured":"Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054\u20131057.","journal-title":"J Clin Invest"},{"key":"352399_CR25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0024-3205(91)90362-F","volume":"48","author":"G Shirakami","year":"1991","unstructured":"Shirakami G, Nakao K, Saito Y. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci 1991;48:969\u2013976.","journal-title":"Life Sci"},{"key":"352399_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0024-3205(90)90327-N","volume":"47","author":"HS Hieda","year":"1990","unstructured":"Hieda HS, Gomez-Sanchez CE. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci 1990;47:247\u2013251.","journal-title":"Life Sci"},{"key":"352399_CR27","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00004872-198900076-00061","volume":"7","author":"M Kohno","year":"1989","unstructured":"Kohno M, Murakawa K, Yokokawa K. Production of endothelin by cultured porcine endothelial cells: modulation by adrenaline. J Hypertens Suppl 1989;7:S130\u2013S131.","journal-title":"J Hypertens Suppl"},{"key":"352399_CR28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0006-291X(90)90370-3","volume":"169","author":"K Ohta","year":"1990","unstructured":"Ohta K, Hirata Y, Imai T. Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun 1990;169:578\u2013584.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/0024-3205(91)90434-D","volume":"48","author":"SM Kanse","year":"1991","unstructured":"Kanse SM, Takahashi K, Lam HC. Cytokine stimulated endothelin release from endothelial cells. Life Sci 1991;48:1379\u20131384.","journal-title":"Life Sci"},{"key":"352399_CR30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0024-3205(91)90193-F","volume":"49","author":"I Miyamori","year":"1991","unstructured":"Miyamori I, Takeda Y, Yoneda T, Iki K, Takeda R. Interleukin-2 enhances the release of endothelin-1 from the rat mesenteric artery. Life Sci 1991;49: 1295\u20131300.","journal-title":"Life Sci"},{"issue":"Suppl1","key":"352399_CR31","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1097\/00005344-199800001-00097","volume":"31","author":"M Woods","year":"1998","unstructured":"Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA, Warner TD. Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells. J Cardiovasc Pharmacol 1998;31Suppl 1:S348\u2013S350.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.HYP.19.2.131","volume":"19","author":"Y Dohi","year":"1992","unstructured":"Dohi Y, Hahn AW, Boulanger CM, B\u00fchler FR, L\u00fcscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992;19:131\u2013137.","journal-title":"Hypertension"},{"key":"352399_CR33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1994.1462","volume":"200","author":"H Macarthur","year":"1994","unstructured":"Macarthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun 1994;200:395\u2013400.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/bbrc.1997.7394","volume":"238","author":"M Barton","year":"1997","unstructured":"Barton M, Shaw S, d'Uscio LV, Moreau P, Luscher TF. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997;238:861\u2013865.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR35","first-page":"H2105","volume":"275","author":"S Maeda","year":"1998","unstructured":"Maeda S, Miyauchi T, Sakai S. Prolonged exercise causes an increase in endothelin-1 production in the heart in rats. Am J Physiol 1998;275:H2105\u2013H2112.","journal-title":"Am J Physiol"},{"key":"352399_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.20.1.89","volume":"20","author":"ZA Abassi","year":"1992","unstructured":"Abassi ZA, Tate JE, Golomb E, Keiser HR. Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 1992;20:89\u201395.","journal-title":"Hypertension"},{"key":"352399_CR37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1476-5381.1993.tb13724.x","volume":"109","author":"ZA Abassi","year":"1993","unstructured":"Abassi ZA, Golomb E, Bridenbaugh R, Keiser HR. Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11. Br J Pharmacol 1993;109:1024\u20131028.","journal-title":"Br J Pharmacol"},{"key":"352399_CR38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(89)90227-X","volume":"78","author":"Y Hirata","year":"1989","unstructured":"Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225\u2013228.","journal-title":"Atherosclerosis"},{"key":"352399_CR39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/348732a0","volume":"348","author":"T Sakurai","year":"1990","unstructured":"Sakurai T, Yanagisawa M, Takuwa Y. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732\u2013735.","journal-title":"Nature"},{"key":"352399_CR40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1476-5381.1992.tb14537.x","volume":"107","author":"MJ Sumner","year":"1992","unstructured":"Sumner MJ, Cannon TR, Mundin JW, White DG, Watts IS. Endothelin ETA and ETB receptors mediate vascular smooth muscle cell contraction. Br J Pharmacol 1992;107:858\u2013860.","journal-title":"Br J Pharmacol"},{"key":"352399_CR41","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.CIR.89.3.1203","volume":"89","author":"B Seo","year":"1994","unstructured":"Seo B, Oemar BS, Siebenmann R, von Segesser L, L\u00fcscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203\u20131208.","journal-title":"Circulation"},{"key":"352399_CR42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/348730a0","volume":"348","author":"H Arai","year":"1990","unstructured":"Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730\u2013732.","journal-title":"Nature"},{"key":"352399_CR43","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1073\/pnas.88.8.3185","volume":"88","author":"HY Lin","year":"1991","unstructured":"Lin HY, Kaji EH, Winkel GK, Ives HE, Lodish HF. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc Natl Acad Sci USA 1991;88:3185\u20133189.","journal-title":"Proc Natl Acad Sci USA"},{"key":"352399_CR44","doi-asserted-by":"crossref","unstructured":"Davenport AP, O'Reilly G, Molenaar P. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtyper-selective ligands BQ123 and BQ3020: evidence for expression of ET(B) receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 1993;22(suppl 8).","DOI":"10.1097\/00005344-199322008-00008"},{"key":"352399_CR45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-291X(92)90826-7","volume":"186","author":"M Clozel","year":"1992","unstructured":"Clozel M, Gray GA, Breu V, L\u00f6ffler B, Osterwalder R. The endothelin ET(B) receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867\u2013873.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.92.3.357","volume":"92","author":"WG Haynes","year":"1995","unstructured":"Haynes WG, Strachan FE, Webb DJ. Endothelin ET(A) and ET(B) receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 1995;92:357\u2013363.","journal-title":"Circulation"},{"key":"352399_CR47","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.CIR.97.8.752","volume":"97","author":"MC Verhaar","year":"1998","unstructured":"Verhaar MC, Strachan FE, Newby DE. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 1998;97:752\u2013756.","journal-title":"Circulation"},{"key":"352399_CR48","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1152\/jappl.1996.81.4.1510","volume":"81","author":"J Dupuis","year":"1996","unstructured":"Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 1996;81: 1510\u20131515.","journal-title":"J Appl Physiol"},{"key":"352399_CR49","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/01.CIR.94.7.1578","volume":"94","author":"J Dupuis","year":"1996","unstructured":"Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578\u20131584.","journal-title":"Circulation"},{"key":"352399_CR50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/bbrc.1995.1527","volume":"209","author":"S Ozaki","year":"1995","unstructured":"Ozaki S, Ohwaki K, Ihara M, Fukuroda T, Ishikawa K, Yano M. ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells.Biochem Biophys Res Commun 1995;209:483\u2013489.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR51","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1006\/bbrc.1994.1395","volume":"199","author":"T Fukuroda","year":"1994","unstructured":"Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994;199:1461\u20131465.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1091\/mbc.1.9.649","volume":"l","author":"AW Hahn","year":"1990","unstructured":"Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1990;l:649\u2013659.","journal-title":"Cell Regul"},{"key":"352399_CR53","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1097\/00005344-199506263-00084","volume":"26","author":"S Eguchi","year":"1995","unstructured":"Eguchi S, Hirata Y, Imai T, Marumo F. Endothelin-1 as an autocrine growth factor for endothelial cells. J Cardiovasc Pharmacol 1995;26:S279\u2013S283.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR54","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1016\/S0021-9258(17)36997-1","volume":"269","author":"GF Alberts","year":"1994","unstructured":"Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem 1994;269:10112\u201310118.","journal-title":"J Biol Chem"},{"key":"352399_CR55","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1074\/jbc.270.12.6997","volume":"270","author":"S Iwasaki","year":"1995","unstructured":"Iwasaki S, Homma T, Matsuda Y, Kon V. Endothelin receptor B subtype B mediates autoinduction of endothelin-1 in rat mesangial cells. J Biol Chem 1995;270:6997\u20137003.","journal-title":"J Biol Chem"},{"key":"352399_CR56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-291X(89)92625-9","volume":"161","author":"A Ohnishi","year":"1989","unstructured":"Ohnishi A, Yamaguchi K, Kusuhara M, Abe K, Kimura S. Mobilization of intracellular calcium by endothelin in Swiss 3T3 cells. Biochem Biophys Res Commun 1989;161:489\u2013495.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0021-9150(85)90059-0","volume":"58","author":"J Nilsson","year":"1985","unstructured":"Nilsson J, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis 1985;58:109\u2013122.","journal-title":"Atherosclerosis"},{"key":"352399_CR58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00005344-199010000-00019","volume":"16","author":"Z Yang","year":"1990","unstructured":"Yang Z, Bauer E, von Segesser L, Stulz P, Turina M, Luscher TF. Different mobilization of calcium in endothelin-1-induced contractions in human arteries and veins: effects of calcium antagonists. J Cardiovasc Pharmacol 1990;16:654\u2013660.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.82.1.188","volume":"82","author":"ZH Yang","year":"1990","unstructured":"Yang ZH, Richard V, von Segesser L. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990;82:188\u2013195.","journal-title":"Circulation"},{"key":"352399_CR60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/01.CIR.83.2.469","volume":"83","author":"W Kiowski","year":"1991","unstructured":"Kiowski W, L\u00fcscher TF, Linder L, B\u00fchler FR. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991;83:469\u2013475.","journal-title":"Circulation"},{"key":"352399_CR61","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.94.3.316","volume":"94","author":"RR Wenzel","year":"1996","unstructured":"Wenzel RR, Duthiers N, Noll G, Bucher J, Kaufmann U, Luscher TF. Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Circulation 1996;94:316\u2013322.","journal-title":"Circulation"},{"key":"352399_CR62","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1016\/S0021-9258(18)41966-7","volume":"267","author":"OF Wagner","year":"1992","unstructured":"Wagner OF, Christ G, Wojta J. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066\u201316068.","journal-title":"J Biol Chem"},{"key":"352399_CR63","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/00365519109104572","volume":"51","author":"SS. Sorensen","year":"1991","unstructured":"Sorensen SS. Radio-immunoassay of endothelin in human plasma. Scand J Clin Lab Invest 1991;51: 615\u2013623.","journal-title":"Scand J Clin Lab Invest"},{"key":"352399_CR64","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(94)92827-4","volume":"344","author":"WG Haynes","year":"1994","unstructured":"Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852\u2013854.","journal-title":"Lancet"},{"key":"352399_CR65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0143-4179(91)90005-4","volume":"18","author":"PG Lysko","year":"1991","unstructured":"Lysko PG, Feuerstein G, Pullen M, Wu HL, Nambi P. Identification of endothelin receptors in cultured cerebellar neurons. Neuropeptides 1991;18:83\u201386.","journal-title":"Neuropeptides"},{"key":"352399_CR66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0143-4179(90)90062-4","volume":"16","author":"P Nambi","year":"1990","unstructured":"Nambi P, Pullen M, Feuerstein G. Identification of endothelin receptors in various regions of rat brain. Neuropeptides 1990;16:195\u2013199.","journal-title":"Neuropeptides"},{"key":"352399_CR67","first-page":"H918","volume":"257","author":"MM Knuepfer","year":"1989","unstructured":"Knuepfer MM, Han SP, Trapani AJ, Fok KF, Westfall TC. Regional hemodynamic and baroreflex effects of endothelin in rats. Am J Physiol 1989;257:H918\u2013H926.","journal-title":"Am J Physiol"},{"key":"352399_CR68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1476-5381.1990.tb14132.x","volume":"101","author":"SM Gardiner","year":"1990","unstructured":"Gardiner SM, Compton AM, Kemp PA, Bennett T. Regional and cardiac haemodynamic responses to glyceryl trmnitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-Larginine methyl ester. Br J Pharmacol 1990;101:632\u2013639.","journal-title":"Br J Pharmacol"},{"key":"352399_CR69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004872-199104000-00005","volume":"9","author":"H Nakamoto","year":"1991","unstructured":"Nakamoto H, Suzuki H, Murakami M. Different effects of low and high doses of endothelin on haemodynamics and hormones in the normotensive conscious dog. J Hypertens 1991;9:337\u2013344.","journal-title":"J Hypertens"},{"key":"352399_CR70","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1161\/01.CIR.84.6.2476","volume":"84","author":"JE Donckier","year":"1991","unstructured":"Donckier JE, Hanet C, Berbinschi A. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation 1991;84:2476\u20132484.","journal-title":"Circulation"},{"key":"352399_CR71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004872-199304000-00008","volume":"11","author":"M van den Buuse","year":"1993","unstructured":"van den Buuse M, Itoh S. Central effects of endothelin on baroreflex of spontaneously hypertensive rats. J Hypertens 1993;11:379\u2013387.","journal-title":"J Hypertens"},{"key":"352399_CR72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-1838(94)90130-9","volume":"49","author":"H Kannan","year":"1994","unstructured":"Kannan H, Tanaka H, Ueta Y, Hayashida Y, Kunitake T, Yamashita H. Effects of centrally administered endothelin-3 on renal sympathetic nerve activity and renal blood flow in conscious rats. J Auton Nerv Syst 1994;49:105\u2013113.","journal-title":"J Auton Nerv Syst"},{"key":"352399_CR73","first-page":"R103","volume":"263","author":"MW Chapleau","year":"1992","unstructured":"Chapleau MW, Hajduczok G, Abboud FM. Suppression of baroreceptor discharge by endothelin at high carotid sinus pressure. Am J Physiol 1992;263:R103\u2013R108.","journal-title":"Am J Physiol"},{"key":"352399_CR74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(98)00365-3","volume":"351","author":"R Mosqueda-Garcia","year":"1998","unstructured":"Mosqueda-Garcia R, Appalsamy M, Fernandez-Violante R, Hamakubo T. Modulatory effects of endothelin on baroreflex activation in the nucleus of the solitary tract. Eur J Pharmacol 1998;351:203\u2013207.","journal-title":"Eur J Pharmacol"},{"key":"352399_CR75","first-page":"F411","volume":"266","author":"SS Sorensen","year":"1994","unstructured":"Sorensen SS, Madsen JK, Pedersen EB. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 1994;266:F411\u2013F418.","journal-title":"Am J Physiol"},{"key":"352399_CR76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI118033","volume":"96","author":"Y Kurihara","year":"1995","unstructured":"Kurihara Y, Kurihara H, Oda H. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 1995;96:293\u2013300.","journal-title":"J Clin Invest"},{"key":"352399_CR77","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI3702","volume":"102","author":"CE Gariepy","year":"1998","unstructured":"Gariepy CE, Williams SC, Richardson JA, Hammer RE, Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J Clin Invest 1998;102:1092\u20131101.","journal-title":"J Clin Invest"},{"key":"352399_CR78","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0092-8674(94)90017-5","volume":"79","author":"K Hosoda","year":"1994","unstructured":"Hosoda K, Hammer RE, Richardson JA. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994;79:1267\u20131276.","journal-title":"Cell"},{"key":"352399_CR79","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0092-8674(94)90018-3","volume":"79","author":"AG Baynash","year":"1994","unstructured":"Baynash AG, Hosoda K, Giaid A. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994;79:1277\u20131285.","journal-title":"Cell"},{"key":"352399_CR80","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng0496-445","volume":"12","author":"RM Hofstra","year":"1996","unstructured":"Hofstra RM, Osinga J, Tan-Sindhunata G. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996;12:445\u2013447.","journal-title":"Nat Genet"},{"key":"352399_CR81","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1242\/dev.125.5.813","volume":"125","author":"DE Clouthier","year":"1998","unstructured":"Clouthier DE, Hosoda K, Richardson JA. Cranial and cardiac neural crest defects in endothelin-A receptordeficient mice. Development 1998;125:813\u2013824.","journal-title":"Development"},{"key":"352399_CR82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/990040","volume":"402","author":"MK Shin","year":"1999","unstructured":"Shin MK, Levorse JM, Ingram RS, Tilghman SM. The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature 1999;402:496\u2013501.","journal-title":"Nature"},{"key":"352399_CR83","first-page":"1158","volume":"74","author":"ME Fant","year":"1992","unstructured":"Fant ME, Nanu L, Word RA. A potential role for endothelin-1 in human placental growth: interactions with the insulin-like growth factor family of peptides. J Clin Endocrinol Metab 1992;74:1158\u20131163.","journal-title":"J Clin Endocrinol Metab"},{"key":"352399_CR84","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM197210192871601","volume":"287","author":"WB Kannel","year":"1972","unstructured":"Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 1972;287:781\u2013787.","journal-title":"N Engl J Med"},{"key":"352399_CR85","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557\u20131562.","journal-title":"JAMA"},{"key":"352399_CR86","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1161\/01.CIR.81.6.1762","volume":"81","author":"L Linder","year":"1990","unstructured":"Linder L, Kiowski W, B\u00fchler FR, L\u00fcscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990;81:1762\u20131767.","journal-title":"Circulation"},{"key":"352399_CR87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199007053230105","volume":"323","author":"JA Panza","year":"1990","unstructured":"Panza JA, Quyyumi AA, Brush JJ, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22\u201327.","journal-title":"N Engl J Med"},{"key":"352399_CR88","volume-title":"The Endothelium: Modulator of Cardiovascular Function","author":"TF L\u00fcscher","year":"1990","unstructured":"L\u00fcscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Ranton: CRC Press, 1990."},{"key":"352399_CR89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ajh\/3.4.317","volume":"317","author":"TF. L\u00fcscher","year":"1990","unstructured":"L\u00fcscher TF. Imbalance of endothelium-derived relaxing and contracting Factors. A new concept in hypertension? Am J Hypertens 1990;317:317\u2013330.","journal-title":"Am J Hypertens"},{"key":"352399_CR90","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.CIR.81.4.1415","volume":"81","author":"H Vierhapper","year":"1990","unstructured":"Vierhapper H, Wagner O, Nowotny P, Waldhausl W. Effect of endothelin-1 in man. Circulation 1990;81:1415\u20131418.","journal-title":"Circulation"},{"key":"352399_CR91","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0008-6363(96)00219-2","volume":"33","author":"DG Kiely","year":"1997","unstructured":"Kiely DG, Cargill RI, Struthers AD, Lipworth BJ. Cardiopulmonary effects of endothelin-1 in man. Cardiovasc Res 1997;33:378\u2013386.","journal-title":"Cardiovasc Res"},{"key":"352399_CR92","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","volume":"69","author":"H Ito","year":"1991","unstructured":"Ito H, Hirata Y, Hiroe M. ET-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991;69:209\u2013215.","journal-title":"Circ Res"},{"key":"352399_CR93","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.HYP.31.1.499","volume":"31","author":"M Barton","year":"1998","unstructured":"Barton M, d'Uscio LV, Shaw S, Meyer P, Moreau P, Luscher TF. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension 1998;31:499\u2013504.","journal-title":"Hypertension"},{"key":"352399_CR94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.100.1.5","volume":"100","author":"Z Yang","year":"1999","unstructured":"Yang Z, Krasnici N, L\u00fcscher TF. Endothelin-1 potentiates smooth muscle cell growth to PDGF: role of ETA and ETB receptor blockade. Circulation 1999;100:5\u20138.","journal-title":"Circulation"},{"key":"352399_CR95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-71-1-89","volume":"71","author":"WB Kannel","year":"1969","unstructured":"Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969;71:89\u2013105.","journal-title":"Ann Intern Med"},{"key":"352399_CR96","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.96.5.1432","volume":"96","author":"ML Bots","year":"1997","unstructured":"Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96:1432\u20131437.","journal-title":"Circulation"},{"key":"352399_CR97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","volume":"340","author":"DH O'Leary","year":"1999","unstructured":"O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14\u201322.","journal-title":"N Engl J Med"},{"key":"352399_CR98","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.100.16.1680","volume":"100","author":"S Taddei","year":"1999","unstructured":"Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation 1999; 100:1680\u20131683.","journal-title":"Circulation"},{"key":"352399_CR99","first-page":"205","volume":"322","author":"Y Saito","year":"1990","unstructured":"Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension [letter]. N Engl J Med 1990;322:205.","journal-title":"N Engl J Med"},{"key":"352399_CR100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-8703(92)90734-D","volume":"123","author":"T Miyauchi","year":"1992","unstructured":"Miyauchi T, Yanagisawa M, Iida K. Age-and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 1992;123:1092\u20131093.","journal-title":"Am Heart J"},{"key":"352399_CR101","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJM199807303390513","volume":"339","author":"WG Haynes","year":"1998","unstructured":"Haynes WG, Ferro CJ, Webb DJ. Bosentan in essential hypertension [letter; comment]. N Engl Med 1998;339:346; discussion 7.","journal-title":"N Engl Med"},{"issue":"Suppl3","key":"352399_CR102","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-199526003-00004","volume":"26","author":"PA Stevens","year":"1995","unstructured":"Stevens PA, Brown MJ. Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995;26Suppl 3:S9\u2013S12.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR103","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.HYP.33.5.1169","volume":"33","author":"L Tiret","year":"1999","unstructured":"Tiret L, Poirier O, Hallet V. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999;33:1169\u20131174.","journal-title":"Hypertension"},{"key":"352399_CR104","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0895-7061(98)00255-6","volume":"12","author":"V Nicaud","year":"1999","unstructured":"Nicaud V, Poirier O, Behague I. Polymorphisms of the endothelin-A and-B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Temoins sur l'Infarctus du Myocarde (ECTIM) Study. Am J Hypertens 1999;12:304\u2013310.","journal-title":"Am J Hypertens"},{"key":"352399_CR105","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00004872-199917090-00007","volume":"17","author":"P Sharma","year":"1999","unstructured":"Sharma P, Hingorani A, Jia H, Hopper R, Brown MJ. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension. J Hypertens 1999;17:1281\u20131287.","journal-title":"J Hypertens"},{"key":"352399_CR106","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.HYP.33.4.954","volume":"33","author":"H Ehmke","year":"1999","unstructured":"Ehmke H, Faulhaber J, Munter K, Kirchengast M, Wiesner RJ. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats. Hypertension 1999;33:954\u2013960.","journal-title":"Hypertension"},{"key":"352399_CR107","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.96.5.1593","volume":"96","author":"P Moreau","year":"1997","unstructured":"Moreau P, d'Uscio LV, Shaw S, Takase H, Barton M, Luscher TF. Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. Circulation 1997;96:1593\u20131597.","journal-title":"Circulation"},{"key":"352399_CR108","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.HYP.29.1.435","volume":"29","author":"LV d'Uscio","year":"1997","unstructured":"d'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, Luscher TF. Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 1997; 29:435\u2013441.","journal-title":"Hypertension"},{"key":"352399_CR109","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.HYP.29.3.763","volume":"29","author":"P Moreau","year":"1997","unstructured":"Moreau P, Takase H, Kung CF, Shaw S, Luscher TF. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension 1997;29:763\u2013769.","journal-title":"Hypertension"},{"key":"352399_CR110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199803193381202","volume":"338","author":"H Krum","year":"1998","unstructured":"Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl Med 1998;338:784\u2013790.","journal-title":"N Engl Med"},{"key":"352399_CR111","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/0002-8703(91)90072-P","volume":"121","author":"JR Teerlink","year":"1991","unstructured":"Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991;121:1852\u20131853.","journal-title":"Am Heart J"},{"key":"352399_CR112","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.CIR.93.5.866","volume":"93","author":"G Noll","year":"1996","unstructured":"Noll G, Wenzel RR, Schneider M. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation 1996;93:866\u2013872.","journal-title":"Circulation"},{"key":"352399_CR113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.HYP.29.1.65","volume":"29","author":"U Ikeda","year":"1997","unstructured":"Ikeda U, Yamamoto K, Maeda Y, Shimpo M, Kanbe T, Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 1997;29:65\u201369.","journal-title":"Hypertension"},{"key":"352399_CR114","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/00005344-199800001-00027","volume":"31","author":"M Kohno","year":"1998","unstructured":"Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Yoshikawa J. Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration. J Cardiovasc Pharmacol 1998; 31:S84\u2013S89.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/01.CIR.88.3.1166","volume":"88","author":"A Lopez Farre","year":"1993","unstructured":"Lopez Farre A, Riesco A, Espinosa G. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993;88:1166\u20131171.","journal-title":"Circulation"},{"key":"352399_CR116","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0049-3848(95)90866-E","volume":"77","author":"R Knofler","year":"1995","unstructured":"Knofler R, Urano T, Malyszko J, Takada Y, Takada A. In vitro effect of endothelin-1 on collagen, and ADP induced aggregation in human whole blood and platelet rich plasma. Thromb Res 1995;77:69\u201378.","journal-title":"Thromb Res"},{"key":"352399_CR117","doi-asserted-by":"crossref","first-page":"H1145","DOI":"10.1152\/ajpcell.1986.250.3.C406","volume":"250","author":"GM Rubanyi","year":"1986","unstructured":"Rubanyi GM, Romero JC, Vanhoutte PM. Flow induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:H1145\u2013H1149.","journal-title":"Am J Physiol"},{"key":"352399_CR118","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.RES.66.4.1088","volume":"66","author":"TF L\u00fcscher","year":"1990","unstructured":"L\u00fcscher TF, Yang Z, Tschudi M. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088\u20131094.","journal-title":"Circ Res"},{"key":"352399_CR119","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.CIR.91.5.1314","volume":"91","author":"R Joannides","year":"1995","unstructured":"Joannides R, Haefeli WE, Linder L. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314\u20131319.","journal-title":"Circulation"},{"key":"352399_CR120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0014-5793(90)80276-O","volume":"267","author":"T Yamauchi","year":"1990","unstructured":"Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine endothelial cells. FEBS Lett 1990;267:16\u201318.","journal-title":"FEBS Lett"},{"key":"352399_CR121","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/clinchem\/42.3.483","volume":"42","author":"L Yildiz","year":"1996","unstructured":"Yildiz L, Akcay F, Kaynar H, Bakan N. Increased plasma endothelin-1 in heavy and light smokers [letter]. Clin Chem 1996;42:483\u2013484.","journal-title":"Clin Chem"},{"key":"352399_CR122","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM199110033251404","volume":"325","author":"A Lerman","year":"1991","unstructured":"Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JJ. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997\u20131001.","journal-title":"N Engl J Med"},{"key":"352399_CR123","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.CIR.99.9.1147","volume":"99","author":"GP Rossi","year":"1999","unstructured":"Rossi GP, Colonna S, Pavan E. Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo. Circulation 1999;99:1147\u20131155.","journal-title":"Circulation"},{"key":"352399_CR124","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/01.CIR.89.4.1573","volume":"89","author":"T Omland","year":"1994","unstructured":"Omland T, Terje Lie R, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89:1573\u20131579.","journal-title":"Circulation"},{"key":"352399_CR125","unstructured":"Spieker LE, Mitrovic V, Noll G. Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure. J Am Coll Cardiol (in press)."},{"key":"352399_CR126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.95.1.221","volume":"95","author":"T Minamino","year":"1997","unstructured":"Minamino T, Kurihara H, Takahashi M. Endothelin converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 1997;95:221\u2013230.","journal-title":"Circulation"},{"key":"352399_CR127","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)90571-1","volume":"344","author":"AM Zeiher","year":"1994","unstructured":"Zeiher AM, Ihling C, Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 1994;344:1405\u20131406.","journal-title":"Lancet"},{"key":"352399_CR128","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/01.CIR.91.4.941","volume":"91","author":"AM Zeiher","year":"1995","unstructured":"Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995;91:941\u2013947.","journal-title":"Circulation"},{"key":"352399_CR129","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1006\/bbrc.1993.1327","volume":"191","author":"JA Winkles","year":"1993","unstructured":"Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191:1081\u20131088.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR130","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1093\/nar\/19.18.5099-a","volume":"19","author":"M Watanabe","year":"1991","unstructured":"Watanabe M, Yanagisawa M, Hamaguchi H, Kanazawa I, Masaki T. TaqI polymorphism at the human preproendothelin-1 gene (EDN1). Nucleic Acids Res 1991;19:5099.","journal-title":"Nucleic Acids Res"},{"key":"352399_CR131","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/nar\/19.11.3161","volume":"19","author":"MR Hoehe","year":"1991","unstructured":"Hoehe MR, Ehrenreich H, Caenazzo L, Berrettini WH. TaqI identifies a four allele DNA polymorphism of the human endothelin-1 gene (EDN1). Nucleic Acids Res 1991;19:3161.","journal-title":"Nucleic Acids Res"},{"key":"352399_CR132","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1093\/nar\/18.20.6176-a","volume":"18","author":"KE Berge","year":"1990","unstructured":"Berge KE, Berg K. A TaqI RFLP at the EDN1 gene locus. Nucleic Acids Res 1990;18:6176.","journal-title":"Nucleic Acids Res"},{"key":"352399_CR133","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/hmg\/2.1.90","volume":"2","author":"JC Pages","year":"1993","unstructured":"Pages JC, Drieu C, Blanche H, Beckmann J, Cann HM. A short tandem repeat polymorphism at the endothelin 1 (EDN1) locus. Hum Mol Genet 1993;2:90.","journal-title":"Hum Mol Genet"},{"key":"352399_CR134","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1053\/euhj.1999.1696","volume":"20","author":"P Charron","year":"1999","unstructured":"Charron P, Tesson F, Poirier O. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 1999;20:1587\u20131591.","journal-title":"Eur Heart J"},{"key":"352399_CR135","doi-asserted-by":"crossref","first-page":"14367","DOI":"10.1073\/pnas.95.24.14367","volume":"95","author":"M Barton","year":"1998","unstructured":"Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Munter K, Luscher TF. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1998;95:14367\u201314372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"352399_CR136","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/01.CIR.99.13.1747","volume":"99","author":"PJ Best","year":"1999","unstructured":"Best PJ, McKenna CJ, Hasdai D, Holmes DR, Jr., Lerman A. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation 1999; 99:1747\u20131752.","journal-title":"Circulation"},{"key":"352399_CR137","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/01.CIR.98.21.2235","volume":"98","author":"RR Wenzel","year":"1998","unstructured":"Wenzel RR, Fleisch M, Shaw S. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation 1998;98:2235\u20132240.","journal-title":"Circulation"},{"key":"352399_CR138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(89)90303-6","volume":"2","author":"T Miyauchi","year":"1989","unstructured":"Miyauchi T, Yanagisawa M, Tomizawa T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction [letter]. Lancet 1989;2:53\u201354.","journal-title":"Lancet"},{"key":"352399_CR139","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/hrt.67.5.383","volume":"67","author":"SG Ray","year":"1992","unstructured":"Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin in acute ischaemic syndromes. Br Heart J 1992;67:383\u2013386.","journal-title":"Br Heart J"},{"key":"352399_CR140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-8703(93)90155-3","volume":"125","author":"H. Tomoda","year":"1993","unstructured":"Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 1993;125:667\u2013672.","journal-title":"Am Heart J"},{"key":"352399_CR141","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1476-5381.1995.tb13296.x","volume":"114","author":"T Watanabe","year":"1995","unstructured":"Watanabe T, Awane Y, Ikeda S. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br J Pharmacol 1995;114:949\u2013954.","journal-title":"Br J Pharmacol"},{"issue":"Suppl3","key":"352399_CR142","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1097\/00005344-199526003-00109","volume":"26","author":"M Kojima","year":"1995","unstructured":"Kojima M, Kusumoto K, Fujiwara S, Watanabe T, Fujino M. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044. J Cardiovasc Pharmacol 1995;26Suppl 3:S365\u2013S368.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl8","key":"352399_CR143","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1097\/00005344-199322008-00089","volume":"22","author":"K Kusumoto","year":"1993","unstructured":"Kusumoto K, Awane Y, Fujiwara S, Watanabe T. Role of endogenous endothelin in extension of rabbit myocardial infarction. J Cardiovasc Pharmacol 1993;22Suppl 8:S339\u2013S342.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR144","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.RES.69.2.370","volume":"69","author":"T Watanabe","year":"1991","unstructured":"Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991;69:370\u2013377.","journal-title":"Circ Res"},{"key":"352399_CR145","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/cvr\/27.9.1613","volume":"27","author":"GJ Grover","year":"1993","unstructured":"Grover GJ, Dzwonczyk S, Parham CS. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993;27:1613\u20131618.","journal-title":"Cardiovasc Res"},{"key":"352399_CR146","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/384353a0","volume":"384","author":"S Sakai","year":"1996","unstructured":"Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353\u2013355.","journal-title":"Nature"},{"key":"352399_CR147","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/01.CIR.95.7.1918","volume":"95","author":"FG Spinale","year":"1997","unstructured":"Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation 1997;95:1918\u20131929.","journal-title":"Circulation"},{"key":"352399_CR148","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.90.5.2510","volume":"89","author":"JR Teerlink","year":"1994","unstructured":"Teerlink JR, Loffler BM, Hess P, Marie JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47\u20130203 (bosentan). Circulation 1994;89:2510\u20132518.","journal-title":"Circulation"},{"key":"352399_CR149","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.73.5.913","volume":"73","author":"WJ Leimbach","year":"1986","unstructured":"Leimbach WJ, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913\u2013919.","journal-title":"Circulation"},{"key":"352399_CR150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819\u2013823.","journal-title":"N Engl J Med"},{"key":"352399_CR151","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","volume":"49","author":"TB Levine","year":"1982","unstructured":"Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659\u20131666.","journal-title":"Am J Cardiol"},{"key":"352399_CR152","doi-asserted-by":"crossref","first-page":"S452","DOI":"10.1097\/00005344-199526003-00133","volume":"26","author":"S Sakai","year":"1995","unstructured":"Sakai S, Yorikane R, Miyauchi T. Altered production of endothelin-1 in the hypertrophied rat heart. J Cardiovasc Pharmacol 1995;26:S452\u2013S455.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR153","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0008-6363(96)00266-0","volume":"33","author":"T Tonnessen","year":"1997","unstructured":"Tonnessen T, Christensen G, Oie E. Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats. Cardiovasc Res 1997;33:601\u2013610.","journal-title":"Cardiovasc Res"},{"key":"352399_CR154","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0735-1097(96)00336-1","volume":"28","author":"S Sakai","year":"1996","unstructured":"Sakai S, Miyauchi T, Sakurai T. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-l messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats. J Am Coll Cardiol 1996;28:1580\u20131588.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR155","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1097\/00005344-199800001-00121","volume":"31","author":"K Huntington","year":"1998","unstructured":"Huntington K, Picard P, Moe G, Stewart DJ, Albernaz A, Monge JC. Increased cardiac and pulmonary endothelin-1 mRNA expression in canine pacinginduced heart failure. J Cardiovasc Pharmacol 1998;31:S424\u2013S426.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR156","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1097\/00005344-199800001-00082","volume":"31","author":"P Picard","year":"1998","unstructured":"Picard P, Smith PJ, Monge JC. Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure. J Cardiovasc Pharmacol 1998;31: S294\u2013S297.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR157","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/01.CIR.82.6.2226","volume":"82","author":"KB Margulies","year":"1990","unstructured":"Margulies KB, Hildebrand FJ, Lerman A, Perrella MA, Burnett JJ. Increased endothelin in experimental heart failure. Circulation 1990;82:2226\u20132230.","journal-title":"Circulation"},{"key":"352399_CR158","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.93.6.1214","volume":"93","author":"S Sakai","year":"1996","unstructured":"Sakai S, Miyauchi T, Sakurai T. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation 1996;93:1214\u20131222.","journal-title":"Circulation"},{"key":"352399_CR159","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.85.2.504","volume":"85","author":"RJ Cody","year":"1992","unstructured":"Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504\u2013509.","journal-title":"Circulation"},{"key":"352399_CR160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0735-1097(92)90183-N","volume":"20","author":"A Lerman","year":"1992","unstructured":"Lerman A, Kubo SH, Tschumperlin LK, Burnett JC, Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol 1992;20:849\u2013853.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR161","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0002-9149(99)80231-8","volume":"76","author":"T Tsutamoto","year":"1995","unstructured":"Tsutamoto T, Hisanaga T, Fukai D. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995;76:803\u2013808.","journal-title":"Am J Cardiol"},{"key":"352399_CR162","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1097\/00005344-199800001-00120","volume":"31","author":"M Fukuchi","year":"1998","unstructured":"Fukuchi M, Giaid A. Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts. J Cardiovasc Pharmacol 1998;31:S421\u2013S423.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR163","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.99.16.2118","volume":"99","author":"O Zolk","year":"1999","unstructured":"Zolk O, Quattek J, Sitzler G. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 1999;99:2118\u20132123.","journal-title":"Circulation"},{"key":"352399_CR164","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0002-9149(99)80783-8","volume":"75","author":"H Krum","year":"1995","unstructured":"Krum H, Goldsmith R, Wilshire-Clement M, Miller M, Packer M. Role of endothelin in the exercise intolerance of chronic heart failure. Am J Cardiol 1995;75:1282\u20131283.","journal-title":"Am J Cardiol"},{"key":"352399_CR165","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0002-9149(93)90543-L","volume":"71","author":"R Pacher","year":"1993","unstructured":"Pacher R, Bergler-Klein J, Globits S. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol 1993;71:1293\u20131299.","journal-title":"Am J Cardiol"},{"key":"352399_CR166","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/oxfordjournals.eurheartj.a015228","volume":"18","author":"F Pousset","year":"1997","unstructured":"Pousset F, Isnard R, Lechat P. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997;18:254\u2013258.","journal-title":"Eur Heart J"},{"key":"352399_CR167","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0735-1097(98)00437-9","volume":"32","author":"M Hulsmann","year":"1998","unstructured":"Hulsmann M, Stanek B, Frey B. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol 1998;32:1695\u20131700.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR168","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.97.8.744","volume":"97","author":"K P\u00f6nicke","year":"1998","unstructured":"P\u00f6nicke K, Vogelsang M, Heinroth M. Endothelin receptors in the failing and nonfailing human heart. Circulation 1998;97:744\u2013751.","journal-title":"Circulation"},{"key":"352399_CR169","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9149(97)00920-X","volume":"81","author":"H Krum","year":"1998","unstructured":"Krum H, Katz SD. Effect of endothelin-1 on exerciseinduced vasodilation in normal subjects and in patients with heart failure. Am J Cardiol 1998;81:355\u2013358.","journal-title":"Am J Cardiol"},{"key":"352399_CR170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/cs0980065","volume":"98","author":"MP Love","year":"2000","unstructured":"Love MP, Haynes WG, Webb DJ, McMurray JJ. Venous endothelin receptor function in patients with chronic heart failure. Clin Sci (Colch) 2000;98:65\u201370.","journal-title":"Clin Sci (Colch)"},{"key":"352399_CR171","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0735-1097(94)90387-5","volume":"23","author":"T Tsutamoto","year":"1994","unstructured":"Tsutamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 1994;23:1427\u20131433.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR172","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/0140-6736(91)92370-H","volume":"338","author":"H Kaufmann","year":"1991","unstructured":"Kaufmann H, Oribe E, Oliver JA. Plasma endothelin during upright tilt: relevance for orthostatic hypotension? Lancet 1991;338:1542\u20131545.","journal-title":"Lancet"},{"key":"352399_CR173","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.CIR.69.3.451","volume":"69","author":"DW Ferguson","year":"1984","unstructured":"Ferguson DW, Abboud FM, Mark AL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 1984;69:451\u2013460.","journal-title":"Circulation"},{"key":"352399_CR174","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.85.2.510","volume":"85","author":"DJ Stewart","year":"1992","unstructured":"Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 1992;85:510\u2013517.","journal-title":"Circulation"},{"key":"352399_CR175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0741-5214(91)90148-N","volume":"14","author":"J Sharefkin","year":"1992","unstructured":"Sharefkin J, Diamond S, Eskin S, McIntire L, Dieffenbach C. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 1992;14:1\u20139.","journal-title":"J Vasc Surg"},{"key":"352399_CR176","first-page":"H103","volume":"263","author":"V. B. Miller Jr","year":"1992","unstructured":"Miller VM, Jr BJC. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol 1992;263:H103\u2013H108.","journal-title":"Am J Physiol"},{"key":"352399_CR177","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.CIR.98.16.1684","volume":"98","author":"J Dupuis","year":"1998","unstructured":"Dupuis J, Rouleau JL, Cernacek P. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Circulation 1998;98: 1684\u20131687.","journal-title":"Circulation"},{"key":"352399_CR178","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0024-3205(97)01064-3","volume":"62","author":"T Kobayshi","year":"1998","unstructured":"Kobayshi T, Miyauchi T, Sakai S. Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? Life Sci 1998;62:185\u2013193.","journal-title":"Life Sci"},{"key":"352399_CR179","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/oxfordjournals.eurheartj.a060446","volume":"15","author":"JM Good","year":"1994","unstructured":"Good JM, Nihoyannopoulos P, Ghatei MA. Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II? Eur Heart J 1994;15:1634\u20131640.","journal-title":"Eur Heart J"},{"key":"352399_CR180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-8703(96)90363-4","volume":"131","author":"H Krum","year":"1996","unstructured":"Krum H, Gu A, Wilshire-Clement M. Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure. Am Heart J 1996;131:337\u2013341.","journal-title":"Am Heart J"},{"key":"352399_CR181","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0008-6363(96)00087-9","volume":"32","author":"S Galatius-Jensen","year":"1996","unstructured":"Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunso S, Kastrup J. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. Cardiovasc Res 1996;32:148\u2013154.","journal-title":"Cardiovasc Res"},{"key":"352399_CR182","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.CIR.93.2.210","volume":"93","author":"B Hornig","year":"1996","unstructured":"Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996;93:210\u2013214.","journal-title":"Circulation"},{"key":"352399_CR183","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.90.2.658","volume":"90","author":"Y Hirooka","year":"1994","unstructured":"Hirooka Y, Imaizumi T, Tagawa T. Effects of Larginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90:658\u2013668.","journal-title":"Circulation"},{"key":"352399_CR184","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0002-9149(97)00096-9","volume":"79","author":"E Mangieri","year":"1997","unstructured":"Mangieri E, Tanzilli G, Barilla F. Isometric handgrip exercise increases endothelin-1 plasma levels in patients with chronic congestive heart failure. Am J Cardiol 1997;79:1261\u20131263.","journal-title":"Am J Cardiol"},{"key":"352399_CR185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236\u2013242.","journal-title":"N Engl J Med"},{"key":"352399_CR186","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/hrt.66.5.356","volume":"66","author":"J McMurray","year":"1991","unstructured":"McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in \u201cchachectic\u201d patients with severe chronic heart failure. Br Heart J 1991;66:356\u2013361.","journal-title":"Br Heart J"},{"key":"352399_CR187","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1681.1994.tb02518.x","volume":"21","author":"H Krum","year":"1994","unstructured":"Krum H, Itescu S. Spontaneous endothelin production by circulating mononuclear cells from patients with chronic heart failure but not from normal subjects. Clin Exp Pharmacol Physiol 1994;21:311\u2013313.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"352399_CR188","first-page":"H2629","volume":"271","author":"PB Thomas","year":"1996","unstructured":"Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, Spinale FG. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol 1996;271:H2629\u2013H2637.","journal-title":"Am J Physiol"},{"key":"352399_CR189","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.101.2.142","volume":"101","author":"PA MacCarthy","year":"2000","unstructured":"MacCarthy PA, Grocott-Mason R, Prendergast BD, Shah AM. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation 2000;101:142\u2013147.","journal-title":"Circulation"},{"key":"352399_CR190","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00165383","volume":"347","author":"HR Zerkowski","year":"1993","unstructured":"Zerkowski HR, Broede A, Kunde K. Comparison of the positive inotropic effects of serotonin, histamine, anglotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol 1993;347:347\u2013352.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"352399_CR191","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI113876","volume":"83","author":"WL Miller","year":"1989","unstructured":"Miller WL, Redfield MM, Burnett JC, Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989;83:317\u2013320.","journal-title":"J Clin Invest"},{"key":"352399_CR192","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0006-291X(89)92479-0","volume":"160","author":"R Morishita","year":"1989","unstructured":"Morishita R, Higaki J, Ogihara T. Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adrenocapsular cells. Biochem Biophys Res Commun 1989;160:628\u2013632.","journal-title":"Biochem Biophys Res Commun"},{"key":"352399_CR193","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1172\/JCI114226","volume":"84","author":"EN Cozza","year":"1989","unstructured":"Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S. Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest 1989;84:1032\u20131035.","journal-title":"J Clin Invest"},{"key":"352399_CR194","first-page":"361","volume":"121","author":"A Otsuka","year":"1989","unstructured":"Otsuka A, Mikami H, Katahira K, Tsunetoshi T, Minamitani K, Ogihara T. Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs. Acta Endocrinol (Copenh) 1989;121:361\u2013364.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"352399_CR195","doi-asserted-by":"crossref","unstructured":"Nakamoto H, Suzuki H, Murakami M. Effects of endothelin on systemic and renal haemodynamics and neuroendocrine hormones in conscious dogs. Clin Sci 989;77:567\u2013572.","DOI":"10.1042\/cs0770567"},{"key":"352399_CR196","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0024-3205(90)90058-Y","volume":"46","author":"K Tsuchiya","year":"1990","unstructured":"Tsuchiya K, Naruse M, Sanaka T. Effects of endothelin on renal hemodynamics and excretory functions in anesthetized dogs. Life Sci 1990;46:59\u201365.","journal-title":"Life Sci"},{"key":"352399_CR197","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1440-1681.1990.tb01318.x","volume":"17","author":"EA Woodcock","year":"1990","unstructured":"Woodcock EA, Tanner JK, Caroccia LM, Little PJ. Mechanisms involved in the stimulation of aldosterone production by angiotensin II, vasopressin and endothelin. Clin Exp Pharmacol Physiol 1990;17:263\u2013267.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"352399_CR198","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.HYP.15.6.744","volume":"15","author":"CE Gomez-Sanchez","year":"1990","unstructured":"Gomez-Sanchez CE, Cozza EN, Foecking MF, Chiou S, Ferris MW. Endothelin receptor subtypes and stimulation of aldosterone secretion. Hypertension 1990;15:744\u2013747.","journal-title":"Hypertension"},{"key":"352399_CR199","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Group (CONSENSUS). N Engl J Med 1987;316:1429.","journal-title":"N Engl J Med"},{"key":"352399_CR200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"SOLVD Investigators.","year":"1991","unstructured":"SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293\u2013302.","journal-title":"N Engl J Med"},{"key":"352399_CR201","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","volume":"90","author":"CIBIS InvestigatorsCommittees.","year":"1994","unstructured":"CIBIS Investigators and Committees. A randomized trial of \u00df-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994;90:1765\u20131773.","journal-title":"Circulation"},{"key":"352399_CR202","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group.","year":"1999","unstructured":"MERIT-HF Study Group. Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001\u20132007.","journal-title":"Lancet"},{"key":"352399_CR203","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(95)91504-4","volume":"346","author":"W Kiowski","year":"1995","unstructured":"Kiowski W, S\u00fctsch G, Hunziker P. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732\u2013736.","journal-title":"Lancet"},{"key":"352399_CR204","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","volume":"98","author":"G S\u00fctsch","year":"1998","unstructured":"S\u00fctsch G, Kiowski W, Yan X-W. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 1998;98:2262\u20132268.","journal-title":"Circulation"},{"key":"352399_CR205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/365759a0","volume":"365","author":"M Clozel","year":"1993","unstructured":"Clozel M, Breu V, Burn K. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993;365: 759\u2013761.","journal-title":"Nature"},{"key":"352399_CR206","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI117046","volume":"93","author":"M Gellai","year":"1994","unstructured":"Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin invest 1994;93:900\u2013906.","journal-title":"J Clin invest"},{"key":"352399_CR207","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(96)00494-3","volume":"310","author":"K Gurbanov","year":"1996","unstructured":"Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, Winaver J. Bosentan improves renal regional blood flow in rats with experimental congestive heart failure. Eur J Pharmacol 1996;310:193\u2013196.","journal-title":"Eur J Pharmacol"},{"key":"352399_CR208","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/01.HYP.33.1.581","volume":"33","author":"FE Strachan","year":"1999","unstructured":"Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 1999;33:581\u2013585.","journal-title":"Hypertension"},{"key":"352399_CR209","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(97)00296-9","volume":"30","author":"A Wada","year":"1997","unstructured":"Wada A, Tsutamoto T, Fukai D. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure. J Am Coll Cardiol 1997;30:1385\u20131392.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR210","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/0002-9149(92)90710-G","volume":"69","author":"H Drexler","year":"1992","unstructured":"Drexler H, Hayoz D, Munzel T. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69:1596\u20131601.","journal-title":"Am J Cardiol"},{"issue":"supplVII","key":"352399_CR211","first-page":"VII\u201392\u201396","volume":"87","author":"D Hayoz","year":"1993","unstructured":"Hayoz D, Drexler H, M\u00fcnzel T. Flow-mediated arteriolar dilation is abnormal in congestive heart failure. Circulation 1993;87(suppl VII):VII\u201392\u201396.","journal-title":"Circulation"},{"key":"352399_CR212","first-page":"H359","volume":"276","author":"JE Lipa","year":"1999","unstructured":"Lipa JE, Neligan PC, Perneault TM. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors. Am J Physiol 1999;276:H359\u2013H367.","journal-title":"Am J Physiol"},{"key":"352399_CR213","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0735-1097(98)00663-9","volume":"33","author":"PJ Cowburn","year":"1999","unstructured":"Cowburn PJ, Cleland JG, McArthur JD. Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 1999;33:932\u2013938","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR214","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0735-1097(98)00564-6","volume":"33","author":"T Inada","year":"1999","unstructured":"Inada T, Fujiwara H, Hasegawa K. Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters. J Am Coll Cardiol 1999;33:565\u2013571.","journal-title":"J Am Coll Cardiol"},{"key":"352399_CR215","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1006\/jmcc.1996.0117","volume":"28","author":"H Ito","year":"1996","unstructured":"Ito H, Adachi S, Tamamori M. Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible role for endogenous endothelin-1-mediated mechanism. J Moll Cell Cardiol 1996;28:1271\u20131277.","journal-title":"J Moll Cell Cardiol"},{"key":"352399_CR216","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","volume":"40","author":"MO Gray","year":"1998","unstructured":"Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998;40: 352\u2013363.","journal-title":"Cardiovasc Res"},{"key":"352399_CR217","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1097\/00005344-199800001-00084","volume":"31","author":"S Sakai","year":"1998","unstructured":"Sakai S, Miyauchi T, Kobayashi T, Yamaguchi I, Goto K, Sugishita Y. Altered expression of isoforms of myosin heavy chain mRNA in the failing rat heart is ameliorated by chronic treatment with an endothelin receptor antagonist. J Cardiovasc Pharmacol 1998;31:S302\u2013S305.","journal-title":"J Cardiovasc Pharmacol"},{"key":"352399_CR218","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.CIR.87.2.464","volume":"87","author":"M Yoshimura","year":"1993","unstructured":"Yoshimura M, Yasue H, Okumura K. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464\u2013469.","journal-title":"Circulation"},{"key":"352399_CR219","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0008-6363(98)00205-3","volume":"39","author":"M Ohnishi","year":"1998","unstructured":"Ohnishi M, Wada A, Tsutamoto T, Fukai D, Kinoshita M. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA\/ETB receptor antagonist in heart failure. Cardiovasc Res 1998;39:617\u2013624.","journal-title":"Cardiovasc Res"},{"key":"352399_CR220","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0008-6363(98)00169-2","volume":"39","author":"GW Moe","year":"1998","unstructured":"Moe GW, Albernaz A, Naik GO, Kirchengast M, Stewart DJ. Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure. Cardiovasc Res 1998;39:571\u2013579.","journal-title":"Cardiovasc Res"},{"key":"352399_CR221","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.HYP.31.3.766","volume":"31","author":"DD Borgeson","year":"1998","unstructured":"Borgeson DD, Grantham JA, Williamson EE. Chronic oral endothelin type A receptor antagonism in experimental heart failure. Hypertension 1998;31:766\u2013770.","journal-title":"Hypertension"},{"key":"352399_CR222","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(05)77807-7","volume":"352","author":"PJ Cowburn","year":"1998","unstructured":"Cowburn PJ, Cleland JG, McArthur JD, MacLean MR, McMurray JJ, Dargie HJ. Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure [letter]. Lancet 1998;352:201\u2013202.","journal-title":"Lancet"},{"key":"352399_CR223","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.94.9.2131","volume":"94","author":"MP Love","year":"1996","unstructured":"Love MP, Haynes WG, Gray GA, Webb DJ, McMurray JJ. Vasodilator effects of endothelinconverting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation 1996;94:2131\u20132137.","journal-title":"Circulation"},{"key":"352399_CR224","first-page":"241A","volume":"34","author":"W Smith","year":"2000","unstructured":"Smith W, Iteld B, LeJemtal T. Improved hemodynamics with the ET(A) selective receptor antagonist BMS-193884 in patients with heart failure. J Am Coll Cardiol 2000;34:241A [abstract].","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011456309039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011456309039\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011456309039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:06:01Z","timestamp":1747998361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011456309039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":224,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["352399"],"URL":"https:\/\/doi.org\/10.1023\/a:1011456309039","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}